Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Jan. 28, 2004

Genzyme Selects Cambridge For Location Of R&D Center

Jan. 21, 2004

Genzyme Selects Cambridge For Location Of R&D Center

Jan. 21, 2004

Alizyme Performs Well In First U.S. Trial Of Renzapride In IBS

Jan. 14, 2004

De Novo Sells License To Lilly For Drug Discovery Software

Jan. 14, 2004

Alizyme Performs Well In First U.S. Trial Of Renzapride In IBS

Jan. 14, 2004

De Novo Sells License To Lilly For Drug Discovery Software

Jan. 14, 2004

Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

Jan. 7, 2004

SkyePharma Disputing GSK's Royalty Payment For Paxil CR

Jan. 7, 2004

SkyePharma Disputing GSK's Royalty Payment For Paxil CR

Jan. 7, 2004

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...